Related Articles
Low molecular thymic peptides improve the deficient immunocytotoxicity of mononuclear cells from tumor patients in vitro
THE INFLUENCE OF THE THYMIC PREPARATION THYMEX-L ON DEFICIENT ANTITUMOR-ACTIVITY OF MONOCYTES FROM MELANOMA PATIENTS IN-VITRO
COMPARISON OF ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS GENERATED BY IL-2 AND IL-7 - CELLULAR MODIFICATIONS INDUCED BY IL-7
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism
Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients.